help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 29, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2802
A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/8/3001    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lowe, H
Right arrow Articles by Silverberg, S J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowe, H
Right arrow Articles by Silverberg, S J
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Calcium and Bone Metabolism

Submitted on December 18, 2006
Accepted on May 23, 2007

Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype

H Lowe, D J McMahon, M R Rubin, J P Bilezikian, and S J Silverberg*

Department of Medicine, College of Physicians and Surgeons, Columbia University. New York, NY, USA

* To whom correspondence should be addressed. E-mail: sjs5{at}columbia.edu.

Context. Patients with elevated parathyroid hormone (PTH) and consistently normal serum calcium levels, in whom secondary causes of hyperparathyroidism have been excluded, may represent the earliest presentation of primary hyperparathyroidism (PHPT).

Objective. To characterize patients with normocalcemic PHPT referred to a Bone Diseases Unit.

Design. Longitudinal cohort study.

Setting. Ambulatory patients referred to metabolic bone disease unit.

Patients. 37 patients (58 yrs, range 32-78; 95% female; serum calcium: 9.4±0.1(SEM) mg/dl (2.3±0.02 mmol/L), reference range: 8.5-10.4 (2.1-2.6 mmol/L); PTH: 93±5 pg/ml).

Interventions. Yearly (median: 3 years; range 1-8y) physical examination, biochemical indices and bone mineral density (BMD).

Main outcome measures. Development of features of PHPT.

Results. Evaluation for classical features of PHPT revealed a history of kidney stones in 5 (14%), fragility fractures in 4 (11%), and osteoporosis in 57% (spine [34%], hip [38%], and/or distal 1/3 radius [28%]). BMD did not show preferential bone loss at the distal 1/3 radius (T-scores spine: -2.00±0.25; hip: -1.84±0.18; 1/3 radius: -1.74±0.22). Further signs of primary hyperparathyroidism developed in 40% (7 hypercalcemia; 1 kidney stone; 1 fracture; 2 marked hypercalciuria; 6 had >10% BMD loss at ≥1 site(s) including 4 patients developing WHO criteria for osteoporosis). Seven patients (3 hypercalcemic, 4 persistently normocalcemic) underwent successful parathyroidectomy.

Conclusions. Patients seen in a referral center with normocalcemic hyperparathyroidism have more substantial skeletal involvement than is typical in PHPT, and develop more features and complications over time. These patients may represent the earliest form of symptomatic, rather than asymptomatic, PHPT.


Key words: PHPT • normocalcemic hyperparathyroidism • osteoporosis




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. Zoehrer, D. W. Dempster, J. P. Bilezikian, H. Zhou, S. J. Silverberg, E. Shane, P. Roschger, E. P. Paschalis, and K. Klaushofer
Bone Quality determined by Fourier Transform Infrared Imaging Analysis in Mild Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3484 - 3489.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society